Bibliography

Found 816 results
2016
Gutierrez J, Menshawy K, Goldman JE, Dwork AJ, Elkind MSV, Marshall RS, Morgello S. Metalloproteinases and brain arterial remodeling with and without HIV. Journal of Infectious Diseases. 2016 ;214(9):1329-1335.
Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki IB, Moore DJ, Masliah E, Achim C. Methamphetamine dependence is associated with cerebral microgliosis in HIV-1 infected adults. Journal of Neurovirology. 2016 ;22.
Var SR, Day TR, Vitomirov A, Smith DM, Soontornniyomkij V, Moore DJ, Achim C, Mehta SR, Pérez-Santiago J. Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS. 2016 ;30(6):839-848.
Levine AJ, Soontornniyomkij V, Achim C, Masliah E, Gelman B. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of Neurovirology. 2016 ;22(4):431-441.
Buzhdygan T, Lisinicchia JG, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman B. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016 ;11(2):279-93.
Bachis A, Wenzel E, Boelk A, Becker J, Mocchetti I. The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice. Neurobiol Aging. 2016 ;46:160-8.
Miranda C, Arce-Renteria M, Fuentes A, Coulehan K, Arentoft A, Byrd D, Rosario A, Monzones J, Morgello S, Rivera-Mindt M. The relative utility of three English language dominance measures in predicting the neuropsychological performance of HIV+ bilingual Lantino/a adults. Clinical Neuropsychology. 2016 .
Dever SM, Rodriguez M, El-Hage N. β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. J Neurovirol. 2016 ;22(6):866-870.
2015
Levine AJ, Quach A, Moore DJ, Achim C, Soontornniyomkij V, Masliah E, Singer EJ, Gelman B, Nemanim N, Horvath S. Accelerated epigenetic aging in brain is associated with pre-mortem HAND. Journal of Neurovirology. 2015 .
Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression. J Acquir Immune Defic Syndr. 2015 ;69(1):18-28.
Jensen BK, Monnerie H, Mannell MV, Gannon PJ, Espinoza CAkay, Erickson MA, Bruce-Keller AJ, Gelman B, Briand LA, R. Pierce C, et al. Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. [Internet]. 2015 ;74(11):1093 - 1118. Available from: http://dx.doi.org/10.1097/NEN.0000000000000255
Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre S, Achim C, Masliah E, Grant I, Moore DJ. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.
Gutierrez J, Goldman JE, Dwork AJ, Elkind MSV, Marshall RS, Morgello S. Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology. 2015 ;85(13):1139-45.
Levine AJ, Soontornniyomkij V, Achim C, Gouaux B, Masliah E, Sinsheimer JS, Singer EJ, Moore DJ. Bridging genetics, histopathology, and neurocognition in the context of HAND. 2015 .
Silva K, Hope-Lucas C, White T, Hairston T-K, Rameau T, Brown A. Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders. J Neurovirol. 2015 ;21(2):174-85.
Dever SM, Rodriguez M, Lapierre J, Costin BN, El-Hage N. Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure. Front Microbiol. 2015 ;6:653.
Coley JS, Calderon TM, Gaskill PJ, Eugenin EA, Berman JW. Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis. PLOS ONEPLOS ONE [Internet]. 2015 ;10(2):e0117450 - . Available from: https://doi.org/10.1371/journal.pone.0117450
Zyskind JW, Wang Y, Cho G, Ting JH, Kolson DL, Lynch DR, Jordan-Sciutto KL. E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity. J Neurochem. 2015 ;132(6):742-55.
Ramos FM, Delgado-Vélez M, Ortiz ÁL, Báez-Pagán CA, Quesada O, Lasalde-Dominicci JA. Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder. J Neurovirol. 2015 .
Fogel GB, Lamers SL, Levine AJ, Valdes-Sueiras M, McGrath MS, Shapshak P, Singer EJ. Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol. 2015 ;21(1):56-65.
Balaji S, Sneha P, Rama M, Shapshak P, Somboonwit C, Kuhn J, Sinnott JT. Global protein sequence variation in HIV-1B isolates derived from human blood and brain in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
Shapshak P, Somboonwit C, Kuhn J, Sinnott JT. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
Thames AD, Briones MS, Magpantay LI, Singer EJ, Martínez-Maza O, Panos SE, Hinkin CH, Levine AJ. HIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation. 2015 .
Kumar A, Fernandez JB, Valdes E, Ownby RL, Kumar M. HIV-1 in the CNS: Serotonergic Deficits and Depression. In: International Society for NeuroVirology. International Society for NeuroVirology. San Diego, CA; 2015.
Horvath S, Levine AJ. HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 ;212(10):1563-73.

Pages